KalVista Pharmaceuticals Inc (KALV)
9.325
+0.36
(+4.07%)
USD |
NASDAQ |
Nov 21, 16:00
9.33
0.00 (0.00%)
After-Hours: 20:00
KalVista Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| April 30, 2020 | 0.00 |
| January 31, 2020 | 0.00 |
| October 31, 2019 | 0.00 |
| July 31, 2019 | 0.00 |
| April 30, 2019 | 0.00 |
| January 31, 2019 | 0.00 |
| October 31, 2018 | 0.00 |
| July 31, 2018 | 0.00 |
| April 30, 2018 | 0.00 |
| January 31, 2018 | 0.00 |
| October 31, 2017 | 0.00 |
| July 31, 2017 | 0.00 |
| April 30, 2017 | 0.00 |
| Date | Value |
|---|---|
| January 31, 2017 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.108 |
| December 31, 2015 | 0.0935 |
| September 30, 2015 | 0.0836 |
| June 30, 2015 | 0.0761 |
| March 31, 2015 | -0.2043 |
| December 31, 2014 | -0.1486 |
| September 30, 2014 | -0.1526 |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | -0.0909 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jan 2020
--
Maximum
Jan 2020
--
Average
--
Median
Jan 2020
Debt to Equity Ratio Benchmarks
| Nuwellis Inc | 0.00 |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 0.00 |
| Xtant Medical Holdings Inc | 0.7605 |
| Myomo Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 200.20M |
| Total Liabilities (Quarterly) | 27.40M |
| Shareholders Equity (Quarterly) | 172.80M |